Down's syndrome: up-regulation of beta-amyloid protein precursor and tau mRNAs and their defective coordination - PubMed (original) (raw)
Comparative Study
Down's syndrome: up-regulation of beta-amyloid protein precursor and tau mRNAs and their defective coordination
F Oyama et al. J Neurochem. 1994 Mar.
Abstract
Almost all patients > 40 years of age with Down's syndrome (DS) develop the pathology characteristic of Alzheimer's disease: abundant beta-amyloid plaques and neurofibrillary tangles. We have investigated the gene expression of beta-amyloid protein precursor (APP) and tau in DS and age-matched control brains and found that levels of both mRNAs were significantly elevated in DS. Such up-regulation was not observed in two other neuronal proteins. A correlation between total APP and tau mRNA levels was also found in DS brain but distinct from the pattern observed in normal brain. Although a proportionality existed between APP-695 mRNA and three-repeat tau mRNA in DS, the proportionality between APP-751 mRNA and four-repeat tau mRNA, which is normally present, was not observed. Thus, DS brains are primarily characterized by the up-regulation of tau mRNA as well as APP mRNA and disruption of the coordinate expression between APP-751 and four-repeat tau.
Similar articles
- A novel correlation between the levels of beta-amyloid protein precursor and tau transcripts in the aged human brain.
Oyama F, Shimada H, Oyama R, Titani K, Ihara Y. Oyama F, et al. J Neurochem. 1992 Sep;59(3):1117-25. doi: 10.1111/j.1471-4159.1992.tb08354.x. J Neurochem. 1992. PMID: 1494902 - Beta-amyloid protein precursor and tau mRNA levels versus beta-amyloid plaque and neurofibrillary tangles in the aged human brain.
Oyama F, Shimada H, Oyama R, Titani K, Ihara Y. Oyama F, et al. J Neurochem. 1993 May;60(5):1658-64. doi: 10.1111/j.1471-4159.1993.tb13388.x. J Neurochem. 1993. PMID: 8473889 - Differential expression of beta amyloid protein precursor (APP) and tau mRNA in the aged human brain: individual variability and correlation between APP-751 and four-repeat tau.
Oyama F, Shimada H, Oyama R, Titani K, Ihara Y. Oyama F, et al. J Neuropathol Exp Neurol. 1991 Sep;50(5):560-78. doi: 10.1097/00005072-199109000-00004. J Neuropathol Exp Neurol. 1991. PMID: 1910077 - Regulation and expression of the Alzheimer's beta/A4 amyloid protein precursor in health, disease, and Down's syndrome.
Beyreuther K, Pollwein P, Multhaup G, Mönning U, König G, Dyrks T, Schubert W, Masters CL. Beyreuther K, et al. Ann N Y Acad Sci. 1993 Sep 24;695:91-102. doi: 10.1111/j.1749-6632.1993.tb23035.x. Ann N Y Acad Sci. 1993. PMID: 8239320 Review. - Alteration of gene expression in Down's syndrome (DS) brains: its significance in neurodegeneration.
Sawa A. Sawa A. J Neural Transm Suppl. 2001;(61):361-71. doi: 10.1007/978-3-7091-6262-0_30. J Neural Transm Suppl. 2001. PMID: 11771759 Review.
Cited by
- The Drosophila homolog of APP promotes Dscam expression to drive axon terminal growth, revealing interaction between Down syndrome genes.
Pizzano S, Sterne GR, Veling MW, Xu LA, Hergenreder T, Ye B. Pizzano S, et al. Dis Model Mech. 2023 Sep 1;16(9):dmm049725. doi: 10.1242/dmm.049725. Epub 2023 Sep 15. Dis Model Mech. 2023. PMID: 37712356 Free PMC article. - Impact of rearrangements on function and position of chromosomes in the interphase nucleus and on human genetic disorders.
Qumsiyeh MB. Qumsiyeh MB. Chromosome Res. 1995 Dec;3(8):455-65. doi: 10.1007/BF00713959. Chromosome Res. 1995. PMID: 8581297 Review. - Cerebrovascular disease emerges with age and Alzheimer's disease in adults with Down syndrome.
Lao P, Edwards N, Flores-Aguilar L, Alshikho M, Rizvi B, Tudorascu D, Rosas HD, Yassa M, Christian BT, Mapstone M, Handen B, Zimmerman ME, Gutierrez J, Wilcock D, Head E, Brickman AM. Lao P, et al. Sci Rep. 2024 May 29;14(1):12334. doi: 10.1038/s41598-024-61962-y. Sci Rep. 2024. PMID: 38811657 Free PMC article. - Regulation of global gene expression and cell proliferation by APP.
Wu Y, Zhang S, Xu Q, Zou H, Zhou W, Cai F, Li T, Song W. Wu Y, et al. Sci Rep. 2016 Mar 3;6:22460. doi: 10.1038/srep22460. Sci Rep. 2016. PMID: 26936520 Free PMC article. - Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model.
Sawa M, Overk C, Becker A, Derse D, Albay R, Weldy K, Salehi A, Beach TG, Doran E, Head E, Yu YE, Mobley WC. Sawa M, et al. Alzheimers Dement. 2022 Jun;18(6):1203-1234. doi: 10.1002/alz.12463. Epub 2021 Nov 10. Alzheimers Dement. 2022. PMID: 34757693 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical